Clinical Trials Directory

Trials / Sponsors / Priovant Therapeutics, Inc.

Priovant Therapeutics, Inc.

Industry · 6 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Lichen Planopilaris
Phase 2 / Phase 32026-03-19
RecruitingA Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)
Cutaneous Sarcoidosis
Phase 22025-04-09
Active Not RecruitingA Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
Uveitis, Posterior, Uveitis, Intermediate, Uveitis
Phase 32024-09-11
CompletedA 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predomin
Dermatomyositis, Dermatomyositis, Adult Type
Phase 22024-08-28
CompletedA Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Non-infectious Pan Uveitis
Phase 22022-11-14
Active Not RecruitingA Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis
Dermatomyositis
Phase 32022-10-31